Literature DB >> 8419894

The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years.

R C Welliver1, L Duffy.   

Abstract

In order to determine if respiratory syncytial virus (RSV)-specific IgE responses at the time of bronchiolitis in infancy are related to recurrent wheezing and pulmonary function at 7-8 years of age, a cohort of 43 infants was identified at the time of their initial RSV bronchiolitis episode. RSV-specific IgE responses in nasopharyngeal secretions were determined, and patients were then followed prospectively with notation of the number of wheezing episodes and exposure to cigarette smoke at home. At 7-8 years of age the patients underwent skin testing to 7 environmental allergens and pulmonary function testing, including pulse oximetry and methacholine challenge. Pulmonary function following inhalation of bronchodilating agents was compared to baseline pulmonary function results in order to determine if abnormalities of pulmonary function were reversible. Recurrent wheezing following bronchiolitis was associated with the initial RSV-IgE response, as well as with a family history of asthma. Current wheezing at age 7-8 years was associated with 2 or more positive skin tests (P < 0.01), a history of exercise-induced wheezing (P = 0.01), and increased sensitivity to methacholine (P < 0.01). Pulmonary function test results were similar for groups with and without recurrent wheezing following bronchiolitis. For the entire study group, RSV-IgE specific responses were unrelated to pulmonary function, but small airway dysfunction was associated with passive smoking (P < 0.025), and both large airway dysfunction and increased airway reactivity were associated with the number of positive skin tests (P < 0.025). Reduced small airway function improved following bronchodilator inhalation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419894     DOI: 10.1002/ppul.1950150104

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  35 in total

1.  Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands.

Authors:  I Lenoir-Wijnkoop; W M C van Aalderen; G Boehm; D Klaassen; A B Sprikkelman; M J C Nuijten
Journal:  Eur J Health Econ       Date:  2010-12-17

2.  Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus.

Authors:  J E Fischer; J E Johnson; R K Kuli-Zade; T R Johnson; S Aung; R A Parker; B S Graham
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Deciphering the importance of host and environmental factors that influence the genesis of asthma during childhood.

Authors:  Peter W Heymann; Thomas A E Platts-Mills
Journal:  J Infect Dis       Date:  2012-09-25       Impact factor: 5.226

4.  Respiratory status and allergy nine to 10 years after acute bronchiolitis.

Authors:  V Noble; M Murray; M S Webb; J Alexander; A S Swarbrick; A D Milner
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

Review 5.  Why do viruses make infants wheeze?

Authors:  I M Balfour-Lynn
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

6.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Allergies in children.

Authors:  Z Chad
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

8.  Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.

Authors:  Dora Estripeaut; Juan Pablo Torres; Cynthia S Somers; Claudia Tagliabue; Shama Khokhar; Vijay G Bhoj; Steve M Grube; Aneta Wozniakowski; Ana M Gomez; Octavio Ramilo; Hasan S Jafri; Asuncion Mejias
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

9.  Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

Authors:  Teresa R Johnson; Michael N Teng; Peter L Collins; Barney S Graham
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Lung function, airway responsiveness, and respiratory symptoms before and after bronchiolitis.

Authors:  S Young; P T O'Keeffe; J Arnott; L I Landau
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.